Skip to content

FIRST CHINA PHARMACEUTICAL GROUP, INC.

company.status.inactive

CIK 1432254fmd_04NR1RQA080QXSM8ZFBXTQGTAKManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Apr 01, 2009 to Sep 30, 2012, 10 periods

Latest quarter · Q3 FY2012

Millions
Total revenues
17
Gross profit
2
Operating income
1
Net income
1
Free cash flow
2
Open Financials

FIRST CHINA PHARMACEUTICAL GROUP, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2011ChangeSource
Total assets$11.8 million10-KT/A 2012-11-19 · proof
Total liabilities$17.8 million10-KT/A 2012-11-19 · proof
Cash and cash equivalents$3.6 million10-KT 2012-05-02 · proof
What are FIRST CHINA PHARMACEUTICAL GROUP, INC.'s total assets?
As of Dec 31, 2011, FIRST CHINA PHARMACEUTICAL GROUP, INC. reported total assets of $11.8 million. Source: the 10-KT/A filed with the SEC on Nov 19, 2012 (restated). SEC
What are FIRST CHINA PHARMACEUTICAL GROUP, INC.'s total liabilities?
As of Dec 31, 2011, FIRST CHINA PHARMACEUTICAL GROUP, INC. reported total liabilities of $17.8 million. Source: the 10-KT/A filed with the SEC on Nov 19, 2012 (restated). SEC
What are FIRST CHINA PHARMACEUTICAL GROUP, INC.'s cash and cash equivalents?
As of Dec 31, 2011, FIRST CHINA PHARMACEUTICAL GROUP, INC. reported cash and cash equivalents of $3.6 million. Source: the 10-KT filed with the SEC on May 2, 2012. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1432254&period_type=annual&limit=5"

Information only, not investment advice.